Thomas Baumert

Thomas Baumert (born May 20, 1965) is a German-French physician-scientist and entrepreneur. He is a Professor of Medicine at the University of Strasbourg and the Chief of the Gastroenterology-Hepatology Service at the . He is the founder of Alentis Therapeutics, a clinical-stage biotech company in Basel. He works on the basic, translational, and clinical investigation of liver disease and cancer.

Baumert and his teams have discovered and developed novel strategies to treat fibrosis and cancer. He has published more than 400 scientific articles including in ''The New England Journal of Medicine'', ''Cell'', ''Nature'', and ''Science Translational Medicine''. His work has been recognized by several awards and honors, including the Galien Prize and the Inserm Research Award. Provided by Wikipedia